Schedule-dependent cytotoxicity of SN-38 in p53 wild-type and mutant colon adenocarcinoma cell lines

This publication has 30 references indexed in Scilit:

• Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice
  Anti-Cancer Drugs, 1996
• Distinct Patterns of Cell Cycle Disturbance Elicited by Compounds Interfering with DNA Topoisomerase I and II Activity
  Experimental Cell Research, 1995
• DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts.
  Genes & Development, 1994
• Chapter 2 Assays of Cell Viability: Discrimination of Cells Dying by Apoptosis
  Published by Elsevier ,1994
• New naphthacenecarboxamide antibiotics, TAN-1518 A and B, have inhibitory activity against mammalian DNA topoisomerase I.
  The Journal of Antibiotics, 1994
• 9-nitro-camptothecin delays growth of U-937 leukemia tumors in nude mice and is cytotoxic or cytostatic for human myelomonocytic leukemia lines in vitro
  European Journal of Haematology, 1993
• Activity of Topotecan, a New Topoisomerase I Inhibitor, Against Human Tumor Colony-Forming Units In Vitro
  JNCI Journal of the National Cancer Institute, 1992
• Camptothecin-stabilized topoisomerase I-DNA adducts cause premature termination of transcription
  Biochemistry, 1990
• DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGS
  Annual Review of Biochemistry, 1989
• DNA TOPOISOMERASES
  Annual Review of Biochemistry, 1985